Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

LymPro JV Partnership before a NAS uplisting? A

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
Posted On: 10/13/2014 11:46:44 AM
Posted By: jpetroinc
Re: Churbz83 #8496
LymPro JV Partnership before a NAS uplisting?

As stated previously, what's interesting now is the somewhat suttle change in verbiage regarding a LymPro JV Partnership:

Quote:


"We project a partnership agreement for LymPro will follow shortly after the completion of the LP-002 study , and the Company is weighing strategic options which include a potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)"
Chairmans Blog 08/10/14



Quote:


"Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification"
GC Incentive Bonus Milestones filing 10/10/14



I would still very much like to know why tying down a LymPro JV Agreement/Partnership continues to be IMHO, nubulous and visceral - now going late into FY14 without it having happened.

Could it be tied to GC's plan to spin out the Diagnostic's Div. and the possibility that he does not want it encumbered with a contract agreement before then? If so, he hasn't said - and IMHO, this question needs to be posed on Twitter....

Peep's have been trumpeting revenue from Lympro since last year. We're fast approaching FY15, and still have no definitive time line, as the LymPro Partnership continues to remain a float on the infamous AMBS milestone schedule...

Read More: http://investorshangout.com/post/view?id=2127...z3G2Y3n1Wc


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us